文献速递免疫规划卫生政策与健康促进

法国2007至2023年全国性HPV疫苗接种率及影响因素研究

Uptake of HPV vaccination and associated factors in France: a nationwide study from 2007 to 2023.
PubMed 文献 · Vaccine · 2026-02-10

基于法国国家健康数据系统(SNDS)纳入10-29岁人群,评估2007-2023年HPV疫苗接种率及社会人口学、医疗利用和医学特征与接种的关联。结果显示接种率自2012年持续上升,2023年10-14岁女性达17.1%、男性达15.7%;社会经济弱势、医疗可及性有限及患慢性病者接种 odds 较低。

要点

  • 2023年10-14岁女性HPV疫苗接种率达17.1%,男性达15.7%。
  • 社会经济弱势与接种 odds 降低相关,且10-19岁女性中差异随时间扩大。
  • 唐氏综合征、糖尿病和精神健康障碍与接种 odds 降低相关。

核心结论

  • 至2023年,弱势年轻人、医疗可及性有限者及慢性病患者从HPV疫苗接种中获益较少。

研究设计与样本

  • 采用多变量逻辑回归模型评估社会人口学、医疗利用与可及性及医学特征与HPV疫苗接种的关联。

主要发现

  • 年度接种率自2012年起持续上升,2023年10-14岁女性达17.1%、男性达15.7%。
  • 社会经济弱势与接种 odds 降低相关:补充健康保险津贴受益者调整OR为0.45-0.84,居住于最贫困五分位市镇者调整OR为0.55-0.73。
  • 10-19岁女性中社会经济差异随时间扩大。
  • 与初级医疗系统接触次数增加与接种概率升高相关;唐氏综合征、糖尿病和精神健康障碍与接种 odds 降低相关。

临床怎么用

  • 应关注社会经济弱势、医疗可及性有限及患慢性病的青少年,针对性提升HPV疫苗接种覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although HPV vaccination coverage has remained low in France, information on barriers to vaccination is incomplete. This nationwide study aimed to assess HPV vaccination uptake and associated factors alongside the evolving recommendations since its implementation. METHODS: Using data from the French National Health Data System (SNDS), all individuals aged 10-29 years were included. Annual HPV vaccination uptake between 2007 and 2023 was assessed by age group and sex. Associations between individuals' socio-demographic, healthcare use and access and medical characteristics with HPV vaccination were assessed using multivariable logistic regression models. FINDINGS: Among 27.9 million (M) individuals included, 5.9M received HPV vaccination: 3.4M (2.7M females/0.7M males) aged 10-14, 2.2M (1.9M/0.3M) aged 15-19, and 0.28M (240,000/40,000) aged 20-29. Annual vaccination uptake consistently increased since 2012, reaching up to 17.1% and 15.7% of 10-14-year-old females and males in 2023. Across all age and sex groups, socioeconomic disadvantage was associated with lower odds of vaccination (adjusted odds ratios ranging from 0.45 to 0.84 for complementary health insurance allowance beneficiaries, and from 0.55 to 0.73 for those living in the most deprived quintile of municipalities), and these disparities widened over time among females aged 10-19. While probability of HPV vaccination increased with the number of contacts with the primary healthcare system, Down syndrome, diabetes and mental health disorders were associated with decreased odds of HPV vaccination. INTERPRETATION: Until 2023, disadvantaged young people, those with limited access to healthcare or suffering from chronic illnesses, benefited less from HPV vaccination than those more privileged.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dufour L, Drouin J, Dray-Spira R, et al. Uptake of HPV vaccination and associated factors in France: a nationwide study from 2007 to 2023. Vaccine. 2026. PMID: 41672032. doi:10.1016/j.vaccine.2026.128308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。